Zura Bio Ltd·4

Jun 22, 4:15 PM ET

Munshi Amit 4

Research Summary

AI-generated summary

Updated

Zura Bio (ZURA) Director Amit Munshi Receives Award of 51,000 Options

What Happened

  • Amit Munshi, a director of Zura Bio Ltd (ZURA), received a derivative award on 2026-06-17 for 51,000 shares/options recorded at $0.00. This was an award/option grant (not an open-market purchase or sale) and does not represent an immediate cash sale or purchase.

Key Details

  • Transaction date: June 17, 2026; Filing date: June 22, 2026 (filed late relative to the typical two-business-day Form 4 window).
  • Reported transaction type: A (award/grant of a derivative security) — 51,000 shares at $0.00.
  • Shares owned after the transaction: Not specified in the provided filing excerpt.
  • Footnote (vesting): The option vests in twelve substantially equal monthly installments over one year from June 17, 2026. Any remaining unvested portion will vest the day before the next annual shareholders’ meeting, subject to continued service.

Context

  • This filing documents a compensation award (an option grant), which is neutral informationally compared with purchases or sales. The filing’s $0.00 amount and the footnote indicate these are vested-over-time derivative awards (options/RSUs), not an immediate stock purchase. The report was filed several days after the transaction date, which is later than the usual two-business-day Form 4 deadline.